Chris Wang

Chris Wang is an experienced professional in the pharmaceutical industry, currently serving as Program Director of Commercial Regulatory Affairs at Genentech since August 2022, specializing in Neuroscience Rare Disease. Prior to this role, Chris held multiple positions at Amgen, including Senior Manager in Business Development - Alliance Management, and various roles in Regulatory Affairs focused on advertising and promotion in multiple business units. Additional experience includes serving as Adjunct Faculty at Rutgers University and a Post-Doctoral Fellowship at Bayer HealthCare. Chris Wang holds a Bachelor of Science in Public Health from the University of Illinois Urbana-Champaign and a Doctor of Pharmacy from the University of Iowa, complemented by an exchange program at Keio University.